1 completed, 1 recruiting, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Olanzapine: new trials by email Literature Review of Olanzapine trials Research Report on Olanzapine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer Olanzapine 2.5 MG, Standard anti-tumor treatment, Nutritional advice - Advanced Cancer, Olanzapine | Phase 3 | Recruiting | Qinghai Red Cross Hospital | 230 | 2024-03-20 | 2024-03-29 |
| HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet - Haloperidol, Advanced Cancer | Phase 3 | Completed | Tan Tock Seng Hospital | 22 | 2022-05-18 | 2026-10-05 |
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer Olanzapine Tablets, Placebo - Olanzapine, CINV | Phase 3 | Unknown | Shi Yanxia | 75 | 2022-01-18 | 2023-02-06 |
Nausea (1) · Testicular Neoplasms (1) · Vomiting (1)
Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Testicular Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Olanzapine (2) · Haloperidol (1) · Solutions (1)
Qinghai Red Cross Hospital (1) · Shi Yanxia (1) · Tan Tock Seng Hospital (1)
China (2) · Singapore (1)
Mervyn Koh (1) · Yanxia Shi, PHD (1)